| Code | 0490D | ||||||||||
| MA number | 20/0032/19-S | ||||||||||
| Product Form: | cps dur 1x125 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 07.02.2019 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Aprepitant Stada 125 mg_cps dur_02/2019_REG.doc
|
| PIL: |
PIL_Aprepitant Stada 80 mg_Aprepitant Stada 125 mg_cps dur_03.2022.pdf
|
| Safety feature | Yes |
| Data update: | 19.06.2023 |
